University of Alabama Preclinical Evidence Suggests Cancer Drugs Can Treat HPVs

University of Alabama at Birmingham preclinical research results suggest that cancer drugs vorinostat, belinostat and panobinostat might be repurposed to treat infections caused by human papillomaviruses (HPVs). HPV infections caused an estimated 266K deaths from cervical cancer worldwide in 2012 according to WHO. It is estimated that 12,200 woman in the U.S. are diagnosed with cervical cancer each year.

Lead Research/Investigator

Sanjib Banerjee, Ph.D., assistant professor of Biochemistry and Molecular Genetics